Raay Neo Pharma launched operations, offering over 90 branded generic formulations across acute and specialty therapy segments.
The company targets 55‑60% of India’s population, covering 13 states including Bihar, Maharashtra, Delhi‑NCR, and Karnataka.
Founder Amit Patni, from the Patni legacy in IT and manufacturing, emphasizes a patient‑first, ethical, and sustainable healthcare model.
Raay Neo Pharma will combine its own branded portfolio with strategic licensing collaborations to expand access to innovative therapies.